The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / An Improved State of Mind?

An Improved State of Mind?

September 4, 2018 • By Arthritis & Rheumatology

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Introduction: Rheumatoid arthritis (RA) causes swelling and pain of the joints (mainly the hands, wrists and feet), reducing functional ability. This can have substantial, negative impact on a patient’s physical and mental quality of life. Pharmacotherapy for RA patients may have a positive impact on mental health outcomes by improving pain and stiffness, potentially by targeting inflammatory processes common to RA and depression.

You Might Also Like
  • Targeted Rheumatoid Arthritis Treatment Does Not Improve Mental Health
  • Mind-Body Techniques for Pain Management
  • Mind-Body Focus Can Improve Treatment, Outcomes in Rheumatic Disease
Explore This Issue
October 2018
Also By This Author
  • Considering Benzbromarone as First-Line Therapy for Gout

Objectives: The objectives of this review, “The Impact of Targeted Rheumatoid Arthritis Pharmacologic Treatment on Mental Health,” were to ascertain the frequency of mental health assessments in RA pharmacotherapy trials, quantify the efficacy of RA pharmacotherapy for mental health outcomes, and explore the clinical and demographic factors related to mental health outcomes.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Evidence suggesting common inflammatory pathways in RA and depression is increasing (see the full study in Arthritis & Rheumatology for citations). Specifically, the levels of inflammatory cytokines, including tumor necrosis factor (TNF) and interleukin-6 (IL-6), can be elevated in individuals with depressive disorder, and recent evidence suggests that therapies used in RA to target TNF inhibitors may improve mental health outcomes in depressed patients with high levels of inflammation and those with chronic physical illness.

Because low mood is highly prevalent in RA, and psychosocial well-being is important to patients, it might be expected that mental health is commonly assessed as an outcome in RA clinical trials. However, a 2009 systematic review found that mental health outcomes were reported in just 4% of RA clinical studies, increasing to 22% with a broader conceptualization of mood, including mental health components of quality of life, using questionnaires.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

These researchers identified and analyzed 71 studies involving 34,706 patients, assessing the frequency of mental health outcome measurement, the impact of RA treatment on mental health and variables associated with the impact of RA treatment on mood outcomes.

Conclusions: Advances in RA treatment have resulted in significant improvements in specific outcomes: the delay of radiographic damage and reduction of inflammation and adverse events. However, this review demonstrates that relying on RA pharmacotherapy alone may not meaningfully improve mental health outcomes. Mental health is treatable in patients with physical illness, and the measurement and management of mental health throughout the course of treatment as part of routine practice is recommended. These results suggest that mental health in patients with RA must be addressed, and that mental health problems are unlikely to resolve with effective pharmacologic management of RA alone. Providing integrated, dedicated mental health care within routine practice is essential to achieve parity of esteem, valuing mental and physical health equally.

Pages: 1 2 | Single Page

Filed Under: Conditions, Rheumatoid Arthritis Tagged With: Arthritis & Rheumatology, Depression, Mental Health, Rheumatoid Arthritis (RA)Issue: October 2018

You Might Also Like:
  • Targeted Rheumatoid Arthritis Treatment Does Not Improve Mental Health
  • Mind-Body Techniques for Pain Management
  • Mind-Body Focus Can Improve Treatment, Outcomes in Rheumatic Disease
  • Lupus in the Child’s Mind

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Patient & Caregiver Resources

Find a rheumatology provider. Learn about your condition and how to live with it. English and Spanish language resources.

View Patient & Caregiver Resources »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)